Federal Supply Schedule 36F79723D0071

Award Date 2/15/23
Last Date to Order 2/14/28
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Bioxcel Therapeutics, Inc. The contract has a ceiling value of $25,000.00 and a period of performance through February 14, 2023. The contract is for an "Interim Agreement under FSS Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products." This indicates the contract provides for the delivery of pharmaceutical and related...
This Federal Supply Schedule contract with the Department of Veterans Affairs (VA) is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Biocon Biologics Inc., a foreign-owned for-profit manufacturer of goods. The contract has a ceiling value of $750,000.00 and a period of performance from March 1, 2024 to February 28, 2029. As a Federal Supply Schedule contract, this is a multiple award, indefinite delivery vehicle that allows federal...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Springworks Therapeutics, Inc. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through April 14, 2024. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows government agencies to procure these...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Civicascript LLC, a non-profit limited liability company. The contract, valued at a ceiling of $225,000.00, is for the delivery of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS to the VA and has a period of performance through August 14, 2029. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows ordering from...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA) to Iovance Biotherapeutics Manufacturing LLC, is for the procurement of drugs, pharmaceuticals, and hematology-related products (Federal Supply Classification 65 I B). The multiple-award contract has a period of performance from September 29, 2024 to September 28, 2029, with a ceiling value of $225,000.00. As a Federal Supply Schedule contract, this vehicle allows federal agencies to purchase the contracted...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, provides interim agreement under FSS Schedule 65 IB for Drugs, Pharmaceuticals, & Hematology Related Products. The contract has a ceiling value of $25,000.00 and a period of performance from February 1, 2025 to July 31, 2025. The prime contractor is Bridgebio Pharma, Inc., a for-profit organization. The contract does not utilize any set-asides and is a multiple award...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Springworks Therapeutics, Inc. for the provision of Drugs, Pharmaceuticals, & Hematology Related Products. The contract has a ceiling value of $300,000.00 and a period of performance from April 15, 2024 to April 14, 2029. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows federal agencies to procure the contracted products and services. The scope of the contract...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12, a civilian agency of the U.S. government, to Genericus, Inc. The contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. This is a multiple award contract with a ceiling value of $850,000.00 and a period of performance ending on December 14, 2029. As a Federal Supply Schedule contract, it allows for the procurement of the specified products and...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the U.S. Department of Veterans Affairs, to Sola Pharmaceuticals, LLC. The contract has a period of performance from June 15, 2023 through June 14, 2028, with a ceiling value of $1,500,000.00. The contract is for the provision of "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS" under Federal Supply Schedule 65 I B. As a Federal Supply Schedule...
  • 36F79723D0071
    Federal Supply Schedule
  • -
    Blanket Purchase Agreements

This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Bioxcel Therapeutics, Inc. on February 15, 2023. The contract, identified as 36F79723D0071, has a ceiling value of $2,225,000.00 and a period of performance extending to February 14, 2028.

The scope of the contract includes the provision of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS to the VA's Veterans Integrated Service Network 12. This indicates that the contract is focused on the delivery of pharmaceutical and hematology-related products to the VA healthcare system. As a Federal Supply Schedule contract, it is a multiple-award vehicle that provides standardized government-wide products and services. The contract does not utilize any set-asides, and Bioxcel Therapeutics, Inc. is a for-profit organization registered in the System for Award Management (SAM) through December 11, 2025.

Generated 2/10/25, 1:38 PM